Navigation Links
CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus
Date:5/5/2009

MURRIETA, Calif., May 5 /PRNewswire/ -- As of May 5, 2009, the World Health Organization, has officially reported 1124 cases of Influenza A (H1N1) infection in 21 different countries. As the situation with the novel H1N1 (Swine Flu) virus continues to evolve, the Centers for Disease Control and Prevention (CDC) continue to update their document Interim Guidance on Specimen Collection and Processing for Patients with Suspected Influenza A (H1N1) Virus. The objective of this document is to provide guidance on appropriate specimen collection, storage, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection.

One of the most widely used methods for detection of H1N1 flu virus is to collect a nasopharyngeal swab sample. The CDC recommends the use of synthetic tip swabs, such as Flocked Swabs, which exhibit a superior recovery of viruses. Several independent scientific studies published in the Journal of Clinical Microbiology and presented at Clinical Virology Symposium show that the quality of the sample taken using Copan Flocked Swabs is comparable to the quality of a sample collected from a nasopharyngeal aspirate or nasal was, which are considered the gold standard for upper respiratory virus samples. The open structure of Copan Flocked Swabs acts like a soft brush that efficiently dislodges and collects cells and mucus, then releases the sample immediately when put in a viral transport medium. In Ontario, the Agency for Health Protection and Promotion also lists Flocked Swabs as the preferred type of swab for respiratory virus sample collection on its latest version of LABstract on H1N1 Flu Virus (human swine influenza), Updated Guidance for Laboratory Testing, Hospital Setting. Copan Flocked Swabs are easy to use, are less invasive and cause minimal discomfort for the patient. Copan holds a worldwide patent on Flocked Swabs.

To transport H1N1 viral specimens collected using swabs, the CDC also recommends that the swab specimen collection vials should contain 1 - 3ml of viral transport medium (e.g. containing, protein stabilizer, antibiotics to discourage bacterial and fungal growth, and buffer solution), such as the BD Universal Viral Transport System, which is manufactured by Copan and distributed in different parts of the world under the Copan brand name Universal Transport Medium (UTM). Copan UTM is room temperature stable and available in vials containing 1 or 3 ml of transport medium for different applications.

About Copan Diagnostics, Inc.

With a reputation for innovation in preanalytics, Copan is the leading manufacturer of collection and transport systems in the world. Copan offers a complete range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
2. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
3. American College of Physicians recommends flu vaccination for health-care workers
4. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
5. FDA Panel Recommends Ban on Cold Medicines for Kids
6. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
7. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
8. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
9. Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius Opposition Slate
10. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
11. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: